Status:
TERMINATED
A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease
Lead Sponsor:
Janssen Pharmaceutical K.K.
Conditions:
Alzheimer's Disease
Dementia
Eligibility:
All Genders
Phase:
PHASE3
Brief Summary
The purpose of this study is to assess the effectiveness and safety of risperidone (an antipsychotic medication) versus placebo for the treatment of patients with hallucinations and delusions associat...
Detailed Description
Dementia is frequently observed in the elderly, often associated with psychotic symptoms such as delusion or hallucination, or with behavioral disturbances such as aggressive behavior, wandering, and ...
Eligibility Criteria
Inclusion
- Diagnosis of Alzheimer's disease according to criteria of Diagnostic and Statistical Manual of Mental Disorders, 4th edition (DSM-IV)
- Mini-Mental State Examination (MMSE) score of not greater than 23
- Behavioral Pathology in Alzheimer's Disease (BEHAVE-AD) psychotic score of \>=2 for any item in the psychotic cluster
- occurrence of hallucination or delusion after onset of symptoms of dementia at least 28 days before screening.
Exclusion
- Patients with a disease that could significantly diminish cognitive function (e.g., Parkinsonism, Huntington's disease, Creutzfeldt-Jacob disease, dementia of Levy body type, vitamin B12 or folic acid deficiency)
- persistent dementia or amnestic disorders according to DSM-IV criteria
- occurrence of hallucination or delusion only while delirium is observed
- psychiatric symptoms induced by psychosis (e.g., schizophrenia, schizoaffective disorders, delusional disorders, depression or bipolar disorders)
- history of neuroleptic malignant syndrome (a rare psychotropic-drug reaction, which may be characterized by confusion, reduced consciousness, high fever or pronounced muscle stiffness)
Key Trial Info
Start Date :
March 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 1 2003
Estimated Enrollment :
33 Patients enrolled
Trial Details
Trial ID
NCT00287742
Start Date
March 1 2002
End Date
March 1 2003
Last Update
May 24 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.